SKIN vs. EYE, BVS, AXGN, BFLY, CBLL, IRMD, AVNS, SIBN, KIDS, and SMLR
Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include National Vision (EYE), Bioventus (BVS), AxoGen (AXGN), Butterfly Network (BFLY), CeriBell (CBLL), Iradimed (IRMD), Avanos Medical (AVNS), SI-BONE (SIBN), OrthoPediatrics (KIDS), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.
Beauty Health vs.
National Vision (NASDAQ:EYE) and Beauty Health (NASDAQ:SKIN) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation.
National Vision has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Comparatively, Beauty Health has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500.
93.3% of Beauty Health shares are owned by institutional investors. 2.3% of National Vision shares are owned by company insiders. Comparatively, 41.0% of Beauty Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
National Vision has higher revenue and earnings than Beauty Health. National Vision is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.
National Vision received 214 more outperform votes than Beauty Health when rated by MarketBeat users. Likewise, 65.30% of users gave National Vision an outperform vote while only 45.98% of users gave Beauty Health an outperform vote.
National Vision currently has a consensus target price of $13.40, indicating a potential upside of 19.43%. Beauty Health has a consensus target price of $2.55, indicating a potential upside of 50.89%. Given Beauty Health's higher possible upside, analysts clearly believe Beauty Health is more favorable than National Vision.
In the previous week, National Vision had 6 more articles in the media than Beauty Health. MarketBeat recorded 17 mentions for National Vision and 11 mentions for Beauty Health. Beauty Health's average media sentiment score of 1.05 beat National Vision's score of 0.54 indicating that Beauty Health is being referred to more favorably in the news media.
National Vision has a net margin of -0.81% compared to Beauty Health's net margin of -8.11%. National Vision's return on equity of 3.52% beat Beauty Health's return on equity.
Summary
National Vision beats Beauty Health on 11 of the 17 factors compared between the two stocks.
Get Beauty Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beauty Health Competitors List
Related Companies and Tools
This page (NASDAQ:SKIN) was last updated on 1/23/2025 by MarketBeat.com Staff
